We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byZachary Archer
Modified over 3 years ago
Copyright © 2013 Elsevier Inc. All rights reserved.Chapter 46 Estrogen Deficiency, Postmenopausal Osteoporosis, and Age-Related Bone Loss Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.1 Cortical porosity index in girls (A) and boys (B). Shaded regions represent the approximate chronological age ranges when the incidence of adolescent forearm fractures peaks based on previous data from Rochester, MN  and elsewhere [220–222]. ***P < vs. Group I; ††p < 0.01, and ††† p < for comparison with the respective group of girls. I, 6–8 yr; II, 9–11 yr; III, 12–14 yr; IV, 15–17 yr; V, 18–21 yr. Source: reproduced from Kirmani et al. , with permission. Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.2 Cross-sectional volumetric bone mineral density (vBMD) data of an age- and sex-stratified population sample from Rochester, MN, assessed by quantitative computerized tomography (QCT) (n = 696) showing patterns of loss of trabecular bone from centrum of vertebrae and cortical bone loss from the distal radius. The age regression in men is shown by the solid line and in women by the broken line. Note that trabecular bone loss is continuous over life in both sexes, with an apparent acceleration at menopause in women. Note also that cortical bone loss does not begin until mid-life in either sex, but the rate of loss is more rapid in women than in men. Source: data are from Riggs et al. , with permission. 3 Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.3 Schematic representation of the role of T cells in the mechanism by which ovariectomy (OVX) promotes osteoclastogenesis, osteoblastogenesis, and hemopoiesis. Estrogen deficiency promotes T-cell activation by increasing the interaction of antigen (Ag) loaded major histocompatibility complex (MHC) molecules with bone marrow macrophages (BMM) and dendritic cells (DC) with the T-cell receptor (TCR). The Ags are likely to be nonself peptides derived from the intestinal macrobiota. T-cell activation also requires at least two costimulatory signals provided by the binding of BMM and DC expressed CD40 and CD80 to the T-cell surface molecules CD40L and CD28, respectively. A critical upstream event is the increased production of reactive oxygen species (ROS), which activate DCs by increasing their expression of CD80. The expansion of T cells in the bone marrow is partially driven by an OVX-induced increase in the thymic output of naïve T cells. Activated T cells secrete tumor necrosis factor (TNF) that stimulates osteoclasts formation primarily by potentiating the response to RANKL. In addition, T cell-expressed CD40L and DLK1/FA-1 increase the osteoclastogenic activity of SC by blunting their secretion of osteoprotegerin (OPG) and augmenting their production of receptor activator of nuclear factor kappa-B ligand (RANKL), macrophage colony-stimulating factor (M-CSF), and other pro-inflammatory factors. Source: reproduced from Pacifici , with permission. 4 Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.4 Schematic representation of the cells and the cytokines by which ovariectomy (OVX) leads to T-cell production of tumor necrosis factor (TNF) and bone loss. The production of transforming growth factor (TGF)β and interleukin (IL)-7 are directly regulated by estrogen. The production of interferon (IFN)γ is a consequence of CD4+ T-cell activation. BMM: bone marrow macrophage; DC: dendritic cell; MHC: major histocompatibility complex; OC: osteoclast; RANKL: receptor activator of nuclear factor kappa-B ligand. Source: from Pacifici , with permission . 5 Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.5 Ovariectomy causes a two-fold lower bone loss in thymectomized (THX) mice than in euthymic controls (SHAM). Bone mineral density (BMD) (mean ± standard error of the mean (SEM)) as measured by dual energy X-ray absorptiometry (DXA). * = p < 0.05 and ** = p < 0.01 as compared to baseline. Source: from Ryan et al. , with permission. 6 Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.6 Changes in serum ionized calcium (Ca) and intact parathyroid hormone (PTH) and urinary free deoxypyridinoline cross-links (fDPD), a bone resorption marker, in 18 early postmenopausal women studied at baseline (BSL) and after 6 months of treatment with physiologic doses of estrogen (EST). At BSL during estrogen deficiency, serum ionized calcium was maintained at a constant level in the presence of increased bone resorption by a reduction in the level of PTH. During estrogen sufficiency, these conditions are reversed. NS: not significant. Source: reproduced from Riggs et al. , with permission. 7 Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.7 Serum parathyroid hormone (PTH) concentrations and bone resorption (assessed by urinary excretion of deoxypyridinoline (DPD)) are increased (p < for both variables) in elderly postmenopausal women as compared with premenopausal women. Either a high calcium (Ca) intake of 2400 mg/day over 3 years or chronic estrogen therapy (ERT) reduced values to those that were similar or lower than in premenopausal women. Source: reproduced from Riggs et al. , with permission. 8 Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.8 Experimental testing of the relative importance of estrogen (E) and testosterone (T) in suppressing bone turnover in 59 elderly men. After 3 weeks of suppression of sex steroid production by gonadotropin-releasing hormone (GnRH) agonist treatment and blocking conversion of androgens to estrogen with an aromatase inhibition, the GnRH agonist, but not the aromatase inhibitor, was discontinued. The subjects were then randomly assigned to groups treated with testosterone, estrogen, both, or neither and treated for 3 weeks before reevaluation. Panel A shows the effects of treatment on the resorption markers, urinary deoxypyridinoline (DPD) and N-telopeptide (NTx). By two-factor ANOVA, estrogen, but not testosterone, prevented increases in bone resorption markers. However, the possibility of a small effect on testosterone on opposing this increase cannot be excluded. Panel B shows the effects on bone formation markers, serum osteocalcin and the N-terminal extension of type I procollagen (PINP). Levels of serum bone alkaline phosphatase did not change (data not shown). Withdrawal of estrogen and testosterone leads to a decrease in markers (indicating that bone formation was being stimulated by their presence). For serum osteocalcin, a marker of late osteoblast function decreases, whereas for serum PINP, a marker of all stages of osteoblast function, estrogen, but not testosterone, was effective. For significance of change from baseline: *p < 0.05; ** p < 0.01; *** p < Source: reproduced from Falahati et al. , with permission. 9 Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013 Elsevier Inc. All rights reserved.FIGURE 46.9 Yearly incidence of fractures as a function of serum estradiol levels in subjects from MrOS Sweden. Poisson regression models were used to determine the relation between serum estradiol levels and fracture risk. Source: reproduced from Mellström et al. , with permission 10 Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 41: Role of Sex Steroids in the Pathogenesis of Osteoporosis Matthew T. Drake and Sundeep Khosla.
Preventing Bone Loss in Early Postmenopausal Women A CME Slide Library From the Council on Hormone Education.
Chapter 12 Chapter 12 Parathyroid Hormone and Parathyroid Hormone-Related Protein Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 31 Chapter 31 Clinical and Epidemiological Studies: Skeletal Changes across Menopause Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 62 Chapter 62 Mechanisms of Bone Destruction in Myeloma Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 72 Chapter 72 Calcium in the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 39 Animal Models for Osteoporosis
Chapter 85 Chapter 85 Parathyroid Hormone Treatment for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Osteoporosis. Background ► The problem Osteoporosis is common Over 50% of women and 30-45% of men over age 50 have osteopenia/osteoporosis White.
Chapter 67 Chapter 67 Biochemical Markers of Bone Turnover in Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 75 Drugs Affecting Calcium Levels and Bone Mineralization.
Chapter 32 Chapter 32 Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization Copyright © 2013 Elsevier Inc. All rights reserved.
Treatment. Bisphosphonates Promotes bone formation and decreases bone resorption Mechanism of Action First line treatment for osteoporosis in both men.
Welcome To Our Presentation
Chapter 3: Osteoclast Biology and Bone Resorption F. Patrick Ross.
Chapter 77 Chapter 77 Estrogen and Estrogen Analogs for Prevention and Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 83 Chapter 83 Denosumab for the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene Aaron Ayenew, Virkamal Dhaliwal, Evan Kostenko, Celeste.
DRUGS THAT AFFECT BONE MINERAL HOMEOSTASIS. Calcium exists in three forms: 50% ionized 40% bound to protein (especially to albumin) 10% complexes.
Hanna Przepiera-Będzak Klinika Reumatologii PAM, Szczecin.
June 2004 Bone Quality Sourced from NIH Consensus Development Panel on Osteoporosis. JAMA 285: ; 2001 Architecture Turnover Rate Damage Accumulation.
OSTEOPOROSIS. Characteristics of osteoporosis include a reduction of bone density and a change in bone structure, both of which increase susceptibility.
By Siraya Kitiyodom ปัญหาที่เกี่ยวกับสุขภาพ ที่พบบ่อยในสตรีวัยทอง และวิธีการดูแล (Part II)
Osteoporosis. Definitions: - - Osteoblasts: Fibroblasts essential for bone formation and mineralization of bone matrix - - Osteoclasts: Cells that break.
Osteoporosis Armed Forces Academy of Medical Sciences.
Lecture 52 Ca ++ Homeostasis PTH Calcitonin 10mg% Vitamin D Normal serum calcium Effect on serum calcium.
Molecular Pathophysiology Musculoskeletal disorders – III Marie Kveiborg.
Osteoporosis in IBD. General Risk Factors for Osteoporosis Advancing age Advancing age Female gender Female gender Family history Family history Alcohol.
Chapter 18 Chapter 18 On the Evolution and Contemporary Roles of Bone Remodeling Copyright © 2013 Elsevier Inc. All rights reserved.
BIOCHEMISTRY BONE METABOLISM MSK BLOCK SYSTEM Nabil Bashir October 1 st, 2009.
Glucocorticoid-Induced Osteoporosis (GIO) Nguyen Thy Khue, MD, PhD Department of Endocrinology, HoChiMinh City University of Medicine and Pharmacy.
Physiology of Bone Dr Taha Sadig Ahmed Physiology Department College of Medicine, King Saud University.
Ch. 6 … ** Need x-rays of fractures **. 6.4 … E. Bone Remodeling - When: % annually in an adult -Function: 1) 2) 3) - Importance of Calcium Nerve.
Physiology of Bone Remodeling Outcomes 1.Compare and contrast the function of osteoblasts and osteoclasts during bone growth, repair, and remodeling. 2.
Osteoporosis. Introduction Osteoporosis is “a disease of the bones that happens when you lose too much bone, make too little bone, or both.” - National.
Chapter 28 Chapter 28 Nutrition and Risk for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
King Abdul Aziz University Faculty Of Pharmacy Department Of Clinical Pharmacy Prepared by: Ahmed Fahad Basilim Supervised by: Dr. Abdurrahman Al Ahdal.
Chapter 29 Chapter 29 Physical Activity and Exercise in the Maintenance of the Adult Skeleton and the Prevention of Osteoporotic Fractures Copyright ©
GLUCOCORTICOID INDUCED OSTEOPOROSIS Sham A. Cader, Michał Banaś, Eugeniusz J. Kucharz Department of Internal Medicine and Rheumatology Medical University.
Osteoporosis Dr. Lauren Phillips Sugar Land Women’s Health.
OSTEOPOROSIS Prof. Dr. Ülkü Akarırmak. Metabolic Bone Diseases Osteosclerosis Osteolysis Osteoporosis is the most common metabolic bone disease.
3 rd Annual Friedman Fellows Symposium November 13 th 2010 Pauline Suwandhi, M.D., Amit Seth, M.D., Ashutosh Pareek, D.O., Vanessa Sy, M.D., Leonid Poretsky,
Chapter 9 Skeletal health. Chapter overview Introduction Biology of bone Osteoporosis: definition, prevalence and consequences Physical activity and bone.
PEER SUPPORT MSK Pharmacology -Virginia Lam. Case study Mary is 78 years old female. She came in to AED after a fall. She said the floor was wet, she.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 14.
May Df: A progressive systemic skeletal disorder characterised by a low bone mass and micro- architectural deterioration of bone. T score of.
How Should We Monitor, Prevent, and Treat Osteoporosis in IBD? All of Our IBD Patients are at Risk and Therefore all Should Begin Treatment at Diagnosis.
The hypothalamo-pituitary-adrenal axis (HPAA) and the female hypothalamo-pituitary-gonadal axis (HPGA).
The Role of Thiazolidinediones in Bone Metabolism David C. Gajzer M.D. Pauline Suwandhi M.D. Yun Feng M.D. Amit K. Seth M.D. Leonid Poretsky M.D. Donna.
© 2017 SlidePlayer.com Inc. All rights reserved.